Process for synthesizing ritonavir

A technology of ritonavir and amino group, which is applied in the field of synthesizing ritonavir, can solve the problems affecting thiazole methylamine group, difficult control of hydrogenolysis debenzyl group selectivity, selectivity problems, etc., to achieve reaction specificity Strong, improved atomic utilization, and cost-reducing effects

Inactive Publication Date: 2004-12-15
XIAMEN UNIV
View PDF2 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0011] The limitation of method 1 is the selectivity problem during the monoacylation of diaminoalcohol under the protection of boron reagent and the trouble of purification of the product
However, since the hydrogenolysis of compound 11 will affect the thiazole methylamine group at the other end, the selectivity conditions for hydrogenolysis to benzylation are not easy to control

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Process for synthesizing ritonavir
  • Process for synthesizing ritonavir
  • Process for synthesizing ritonavir

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0022] Below by embodiment the present invention will be further described.

[0023] Step 1 Benzylaminoalcohol 1 (696mg, 1.5mmol) was dissolved in anhydrous dichloromethane (30ml). Cool to -20°C. A solution of N-carboxylic acid internal anhydride 8 in dichloromethane (2.25ml, 2.25mmol) was slowly added dropwise. After the addition was complete, 30 ml of a dichloromethane solution of triethylamine (0.27 ml, 1.92 mmol) was slowly added dropwise over 10 min. React at -13~-17°C for 2 hours. Adjust the pH to 4 with concentrated hydrochloric acid. Adjust the pH to 8-9 with saturated sodium bicarbonate solution. wash. Dry over anhydrous sodium sulfate. Concentrate under reduced pressure to obtain 991 mg of valyl ampicillin.

[0024] 1 H NMR (CDCl 3 , 500MHz) δ7.05-7.35(m, 20H), 4.12(m, 1H), 3.90(d, J=13.3Hz, 2H), 3.57(dt, J=2.2×8.1Hz, 1H), 3.38(d , J=14.2Hz, 2H), 3.10(d, J=4.1Hz, 1H), 3.04(dd, J=14.2×5.8Hz, 1H), 2.62-2.82(m, 4H), 2.15(m, 1H) , 1.57(m, 2H), 1.53(m, 2H), 1.3...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to the synthesis process of Ritonavir as one proteinase inhibitor for resisting AIDS. The synthesis process includes the condensation between benzylamino alcohol and valine NCA to obtain valyl benzylamino alcohol, the reaction between valyl benzylamino alcohol and ditert-butyl dicarbonate to obtain tert-butoxy acyl valyl benzylamino alcohol, the hydrogenolysis and debenzylation of tert-butoxy acyl valyl benzylamino alcohol in ammonium formate and Pd-C to obtain tert-butoxy acyl valyl amino alcohol, the active esterification reaction between tert-butoxy acyl valyl amino alcohol and 5-methylol thiazole, subsequent hydrolysis to obtain thiazolyl-5-methoxycarbonyl valyl amino alcohol, and the reaction of thiazolyl-5-methoxycarbonyl valyl amino alcohol and isopropyl thiazolyl methylamine under the action of BTC to obtain final product Ritonavir. The present invention has lowered cost and raised atomic utilization.

Description

(1) Technical field [0001] The invention relates to a method for synthesizing ritonavir, an anti-AIDS protease inhibitor. (2) Background technology [0002] Ritonavir, chemical name: (5S, 8S, 10S, 11S)-10-hydroxy-2-methyl-5-(1-methylethyl)-1-[2-(1-methylethyl)-4- Thiazolyl]-3,6-dioxo-8,11-bis(benzyl)-2,4,7,12-tetraazatridecyl-13-carboxylic acid, 5-thiazole methyl ester (CAS No. 155213-67-5) is a protease inhibitor against AIDS HIV-1 and HIV-2 (Proc. Natl. Acad. Sci. USA, 1995, 92, 2484). The structural formula of ritonavir is as follows: [0003] [0004] From the structural analysis of ritonavir, it can be divided into four fragments. I is a fragment of 5-hydroxythiazole, IV is a fragment of isopropylthiazole methylamine, III is a fragment of valine, and II is a fragment of chiral aminoalcohol. According to patents and literature reports, the synthesis of ritonavir includes the following processes: (a) synthesis of two thiazole fragments (I and IV), (b) synthesis of ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61P31/18C07D277/28
Inventor 靳立人许志杰蒋洪平
Owner XIAMEN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap